> I think the difference is releasing self driving provides the data Tesla needs to improve it. Releasing a half baked drug doesn't help the pharma company impr

> I think the difference is releasing self driving provides the data Tesla needs to improve it. Releasing a half baked drug doesn't help the pharma company improve it. The pharma company could see results (self-driving car data) and figure out what caused the issues (details of the deaths in pharma, accidents in Tesla) and use that to make the next beta version. I don't really see how that isn't an apt analogy. It's called clinical trials for pharma the key point being it's opt in and doesn't affect anyone around the subject, unlike Tesla's autopilot beta.